CRB Monitor Securities Database Updates
During the week of November 17 - 23, 2025, CRB Monitor’s research team made several updates to securities’ information and added source documents & relevant news articles to the CRB Monitor database.
Summary of the updates for the Week of November 17 - 23, 2025:
|
Tier |
Total # |
Active / Inactive / Pre-IPO |
Added |
Removed |
Net Change |
|
Tier 1A |
147 |
122 / 23 / 2 |
+0 | -0 | +0 |
|
Tier 1B |
699 |
548 / 149 / 2 |
+0 | -0 | +0 |
|
Tier 2 |
290 |
271 / 14 / 5 |
+0 | -0 | +0 |
|
Tier 3 |
417 |
392 / 24 / 1 |
+0 | -2 | -2 |
|
Total Issuances |
1,553 |
1,333 / 210 / 10 |
+0 | -2 | -2 |
|
Total Issuers (w/o Pre-IPOs) |
1,147 |
- |
+0 | -1 | -1 |
|
Total Issuers (w/ Pre-IPOs) |
1,157 |
- |
+0 | -1 | -1 |
Removed 2 Tier 3 Securities:
- -2 = Discarded Business Record: ("Theralase Technologies Inc.") - 1 Issuer with 2 Issuances: 1 Common (Active) & 1 Warrant (Inactive)
- Rationale = Theralase Technologies Inc., based in Canada, is a biotechnology company focused on the commercialization of medical devices. Theralase Technologies also operates as a clinical stage pharmaceutical company focused on various cancers. Theralase Technologies was previously involved in the cannabis industry through the development of hemp-derived cannabidiol (CBD) products. However, it has been over two years since there has been any mention of cannabis in connection with this company. There is no evidence to suggest that this company is still actively engaged in the cannabis industry. As a result, this business no longer qualifies for inclusion.
All newly-identified CRBs during the week:
|
Company Name |
Tier |
Pure-Play | Sector |
Description |
|
N/A |
N/A | N/A | N/A |
N/A |